Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Neuroscience
... of 3.8% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$29.9 Billion by the end of the analysis period. ... Read More
-
Nocturia Drugs
... at a CAGR of 6.1% over the analysis period 2023-2030. Low Nocturnal Bladder Capacity Indication, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.0 Billion by ... Read More
-
Non-Melanoma Skin Cancer
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 ... Read More
-
Sperm Banks
... at a CAGR of 5.3% over the analysis period 2023-2030. Sperm Storage Service, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end ... Read More
-
Statins
... of 1.8% over the analysis period 2023-2030. Synthetic Statins, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$12.2 Billion by the end of the analysis period. ... Read More
-
Allergy Immunotherapy
... at a CAGR of 9.4% over the analysis period 2023-2030. Subcutaneous Immunotherapy (SCIT), one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$3.4 Billion by the end ... Read More
-
Family Planning Centers
... by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion ... Read More
-
NDDS in Cancer Therapy
... reach US$73.2 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2023-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$67.8 ... Read More
-
Psychiatric and Substance Abuse Hospitals
... is expected to reach US$42.0 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a ... Read More
-
Idiopathic Pulmonary Fibrosis
... by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Retail Pharmacies Distribution Channel, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$3.5 ... Read More
-
Orthopedic Surgical Robots
... by 2030, growing at a CAGR of 40.3% over the analysis period 2023-2030. Knee Surgery End-Use, one of the segments analyzed in the report, is expected to record a 37.8% CAGR and reach US$6.6 Billion ... Read More
-
Orthopedic Software
... at a CAGR of 6.4% over the analysis period 2023-2030. Orthopedic PACS Software, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$219.4 Million by the end ... Read More
-
Heart Failure Drugs
... by 2030, growing at a CAGR of 12.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 16.2% CAGR The Heart Failure Drugs market ... Read More
-
Immuno-Oncology
... of 16.2% over the analysis period 2023-2030. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$75.1 Billion by the end of the analysis ... Read More
-
Cancer Immunotherapy
... at a CAGR of 13.6% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$266.2 Billion by the end of ... Read More
-
Periodontal Therapeutics
... at a CAGR of 8.6% over the analysis period 2023-2030. Systemic Antibiotics, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$623.3 Million by the end of ... Read More
-
Bioprosthetics
... of 9.5% over the analysis period 2023-2030. Xenograft Bioprosthetics, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.3 Billion by the end of the analysis period. ... Read More
-
Skin Tightening
... at a CAGR of 6.0% over the analysis period 2023-2030. Radio Frequency Skin Tightening, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by the ... Read More
-
Gastrointestinal Videoscopes
... at a CAGR of 6.3% over the analysis period 2023-2030. Hospitals Application, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$5.3 Billion by the end of ... Read More
-
Cancer Biomarkers
... at a CAGR of 16.8% over the analysis period 2023-2030. Protein Biomarkers, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$42.9 Billion by the end of ... Read More
-
Canine Atopic Dermatitis
... by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Clinics), and Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to growing prevalence of cataract and increasing geriatric population. The cataract ... Read More
-
Cancer Registry Software
... by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Standalone Software, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$116.6 Million by ... Read More
-
Head and Neck Cancer Therapeutics
... is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More
-
Hypertrophic and Keloid Scar Treatment
... Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Topical Treatment , one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$7.3 ... Read More
Research Assistance
